Appendix 4G
170901_Appendix 4G
Investor Presentation (August)
170830_Investor Presentation Update
Shareholders Update
170822_Shareholders Update
Epichem Reports Record $3m Revenues and Expands Laboratory to Accelerate Growth
170717_Epichem Reports Record $3m Revenues and Expands Laboratory to Accelerate Growth
Appendix 4E & Annual Report
170901_Appendix 4E & Annual Report
Appendix 4C – Quarterly Report & Company Update for the period ended 30 June 2017
170801_Appendix 4C – Quarterly Report & Company Update for the period ended 30 June 2017
PharmAust engages Canadian-based specialists to reformulate monepantel
170627_PharmAust engages Canadian-based specialists to reformulate monepantel
